세계의 제산제 시장 규모 조사 및 예측 : 제형별(정제, 분말, 기타), 유통 채널별(병원 약국, E-Commerce, 기타), 지역별 분석(2023-2030년)

Global Antacids Market is valued approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Antacid is a sort of medicine that aids to reduce stomach acid and alleviates symptoms associated to excess acid. These over-the-counter medications have sodium bicarbonate, calcium, magnesium, or aluminum as active ingredients. They function by combining with stomach acid to create neutral chemicals that can lessen the acidity of the stomach contents. Antacids can therefore be used to treat symptoms including indigestion, heartburn, and acid reflux. Antacids are frequently used to treat symptoms brought on by excessive stomach acid. They aid in balancing the acid that is responsible for the burning in the chest or stomach. The key factor driving the market growth is rising prevalence of acid reflux and GERD, easy availability of OTC antacids, and rise in the demand for antacids among geriatric population that anticipated to support the market growth during forecast period.

Moreover, the rising geriatric population is one of the factors contributing to the growth of the antacids market. As people age, they are more prone to developing gastrointestinal problems such as acid reflux, heartburn, and gastroesophageal reflux disease (GERD). These conditions can cause discomfort and pain in the chest and throat and can also lead to other health complications. Thus, the rising geriatric population is anticipated to support the market growth. According to The World Bank, in 2015, the number of people aged 65 and above in India was 74.61 million and the number reached 95.75 million in 2021. Also, according to the same source, in 2016, the 22% of total population ages 65 and above in Italy and the number is reached 24% in 2021. As a result, the rising geriatric population in the region is anticipated to create a lucrative demand for the market. Additionally, rapidly changing lifestyle of global population is anticipated to create the lucrative opportunity for the market during forecast period. However, the growing number of alternatives in the market for antacids may stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antacids Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of key market players, availability of well-developed healthcare infrastructure, increase in incidences of heart burn cases, and easy availability of over-the-counter medication in this region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric population, growing presence of pharmaceutical companies, increase in healthcare expenditure and rise in awareness among people about heart burn are expected to drive market growth.

Major market players included in this report are:

• Abbott Laboratories
• Alkem Laboratories Ltd.
• Bayer AG
• Cipla Ltd
• Haleon plc
• Infirst Healthcare Inc.
• Pfizer Inc.
• Prestige Consumer Healthcare Inc.
• Reckitt Benckiser Group PLC,
• WellSpring Pharmaceutical Corporation

Recent Developments in the Market:

• In June 2022, Zydus Lifesciences received final approval from the United States Food and Drug Administration (FDA) to market Famotidine tablets in the strengths of 20 mg and 40 mg. Famotidine is a histamine H2 receptor blocker. It works by reducing the amount of acid in the stomach.

Global Antacids Market Report Scope:

• Historical Data: - 2020 - 2021
• Base Year for Estimation: - 2022
• Forecast period: - 2023-2030
• Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: - Formulation Type, Distribution Channel, Region
• Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Formulation Type:

• Tablet
• Powder
• Others

By Distribution Channel:

• Hospital Pharmacies
• E-Commerce
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Antacids Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Antacids Market, by Formulation Type, 2020-2030 (USD Billion)
  • 1.2.3. Antacids Market, by Distribution Channel, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Antacids Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Antacids Market Dynamics

• 3.1. Antacids Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of acid reflux and GERD
    • 3.1.1.2. Easy availability of OTC antacids
    • 3.1.1.3. Rise in the demand for antacids among geriatric population
  • 3.1.2. Market Challenges
    • 3.1.2.1. Availability of substitute
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rapidly changing lifestyle of global population

Chapter 4. Global Antacids Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Antacids Market, by Formulation Type

• 5.1. Market Snapshot
• 5.2. Global Antacids Market by Formulation Type, Performance - Potential Analysis
• 5.3. Global Antacids Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
• 5.4. Antacids Market, Sub Segment Analysis
  • 5.4.1. Tablet
  • 5.4.2. Powder
  • 5.4.3. Others

Chapter 6. Global Antacids Market, by Distribution Channel

• 6.1. Market Snapshot
• 6.2. Global Antacids Market by Distribution Channel, Performance - Potential Analysis
• 6.3. Global Antacids Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
• 6.4. Antacids Market, Sub Segment Analysis
  • 6.4.1. Hospital Pharmacies
  • 6.4.2. E-Commerce
  • 6.4.3. Others

Chapter 7. Global Antacids Market, Regional Analysis

• 7.1. Top Leading Countries
• 7.2. Top Emerging Countries
• 7.3. Antacids Market, Regional Market Snapshot
• 7.4. North America Antacids Market
  • 7.4.1. U.S. Antacids Market
    • 7.4.1.1. Formulation Type breakdown estimates & forecasts, 2020-2030
    • 7.4.1.2. Distribution Channel breakdown estimates & forecasts, 2020-2030
  • 7.4.2. Canada Antacids Market
• 7.5. Europe Antacids Market Snapshot
  • 7.5.1. U.K. Antacids Market
  • 7.5.2. Germany Antacids Market
  • 7.5.3. France Antacids Market
  • 7.5.4. Spain Antacids Market
  • 7.5.5. Italy Antacids Market
  • 7.5.6. Rest of Europe Antacids Market
• 7.6. Asia-Pacific Antacids Market Snapshot
  • 7.6.1. China Antacids Market
  • 7.6.2. India Antacids Market
  • 7.6.3. Japan Antacids Market
  • 7.6.4. Australia Antacids Market
  • 7.6.5. South Korea Antacids Market
  • 7.6.6. Rest of Asia Pacific Antacids Market
• 7.7. Latin America Antacids Market Snapshot
  • 7.7.1. Brazil Antacids Market
  • 7.7.2. Mexico Antacids Market
• 7.8. Middle East & Africa Antacids Market
  • 7.8.1. Saudi Arabia Antacids Market
  • 7.8.2. South Africa Antacids Market
  • 7.8.3. Rest of Middle East & Africa Antacids Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
  • 8.1.1. Company 1
  • 8.1.2. Company 2
  • 8.1.3. Company 3
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Abbott Laboratories
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Recent Developments
  • 8.3.2. Alkem Laboratories Ltd.
  • 8.3.3. Bayer AG
  • 8.3.4. Cipla Ltd
  • 8.3.5. Haleon plc
  • 8.3.6. Infirst Healthcare Inc.
  • 8.3.7. Pfizer Inc.
  • 8.3.8. Prestige Consumer Healthcare Inc.
  • 8.3.9. Reckitt Benckiser Group PLC,
  • 8.3.10. WellSpring Pharmaceutical Corporation

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes
• 9.3. Research Assumption